November 2014 Briefing - Dermatology

Share this content:

Here are what the editors at HealthDay consider to be the most important developments in Dermatology for November 2014. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Health Care Organizations See Value of Telemedicine

WEDNESDAY, Nov. 26, 2014 (HealthDay News) -- Health care organizations are developing and implementing telemedicine programs, although many have yet to receive reimbursement, according to a report published by Foley & Lardner.

More Information

Newly Insured Under ACA May Have Trouble Finding Doctors

MONDAY, Nov. 24, 2014 (HealthDay News) -- Millions of Americans bought health insurance coverage through the Affordable Care Act in the past year and physicians may be reluctant to accept these patients.

HealthCare.gov
Full Article

Eczema Cases Rising Among U.S. Children

MONDAY, Nov. 24, 2014 (HealthDay News) -- A growing number of children are being diagnosed with eczema -- but it can usually be eased with topical treatments, according to a new report by the American Academy of Pediatrics (AAP) published online Nov. 24 in Pediatrics.

Full Article
Abstract
Full Text

Lasting Results for Laser Tx of Photoaging in Asian Skin

FRIDAY, Nov. 21, 2014 (HealthDay News) -- Fractional CO2 laser resurfacing may be useful in the treatment of photoaging in Asian patients, according to research published online Nov. 16 in Lasers in Surgery and Medicine.

Abstract
Full Text (subscription or payment may be required)

AMA: Gender Inequality Still Exists in Medicine

FRIDAY, Nov. 21, 2014 (HealthDay News) -- Gender inequality still exists in medicine, according to an article published by the American Medical Association (AMA).

More Information

Bacterial Pathogens Identified in Hidradenitis Suppurativa Lesions

FRIDAY, Nov. 21, 2014 (HealthDay News) -- Bacteria that are known to cause soft tissue and skin infections have been found in association with hidradenitis suppurativa (HS) lesions, according to a study published in the December issue of the U.S. Centers for Disease Control and Prevention's Emerging Infectious Diseases.

Full Text (subscription or payment may be required)

Effect of Interventions to Improve Meds Adherence Vary

FRIDAY, Nov. 21, 2014 (HealthDay News) -- The effects of trials to improve medication adherence are inconsistent, with few studies of the highest quality demonstrating improvement in both adherence and clinical outcome, according to a review published online Nov. 20 in The Cochrane Library.

Abstract
Full Text (subscription or payment may be required)

Genetic Diversity May Improve Tx Response in Melanoma

THURSDAY, Nov. 20, 2014 (HealthDay News) -- Evidence suggests a genetic basis for clinical response to cytotoxic T-lymphocyte antigen 4 (CTLA-4) blockade in melanoma, according to research published online Nov. 19 in the New England Journal of Medicine.

Abstract
Full Text
Editorial

Dermatologists Present Seven Referral Tips for Rheumatologists

THURSDAY, Nov. 20, 2014 (HealthDay News) -- Dermatologists and rheumatologists often refer to one another, and in an article published in the November issue of The Rheumatologist, dermatologists present seven tips for rheumatologists to improve this collaboration.

More Information

Treatments Show Promise in Metastatic Melanoma

TUESDAY, Nov. 18, 2014 (HealthDay News) -- In metastatic melanoma, nivolumab improves overall and progression-free survival versus dacarbazine, and dabrafenib plus trametinib improves survival versus vemurafenib monotherapy, according to two studies published online Nov. 16 in the New England Journal of Medicine.

Abstract 1
Full Text
Abstract 2
Full Text

Triple Aim Should Be Expanded to Address Physician Burnout

FRIDAY, Nov. 14, 2014 (HealthDay News) -- Expanding the Triple Aim approach -- which includes enhancing patient experience, improving population health, and reducing costs -- to the Quadruple Aim by adding the goal of improving health care provider work life is recommended, according to the authors of an article published in the November/December issue of the Annals of Family Medicine.

Abstract
Full Text

Patient-Controlled Taping Method Effective for Ingrown Toenails

THURSDAY, Nov. 13, 2014 (HealthDay News) -- A novel patient-controlled taping method is effective for the treatment of ingrown toenails, according to research published in the November/December issue of the Annals of Family Medicine.

Abstract
Full Text

U.S. Prices Soaring for Some Generic Drugs

THURSDAY, Nov. 13, 2014 (HealthDay News) -- Market forces are dramatically driving up the cost of some generic drugs, prompting U.S. investigations into the pricing of what should be cheap alternatives to brand-name medications.

Full Article
Full Text

CDC: Skin Cancer Costs Soar Compared to Other Cancers

MONDAY, Nov. 10, 2014 (HealthDay News) -- The cost of skin cancer treatment in the United States more than doubled between 2002 and 2011, and rose five times faster than treatments for other cancers, according to study findings published online Nov. 9 in the American Journal of Preventive Medicine.

Full Article
Abstract
Full Text

Aspirin May Exacerbate Chronic Urticaria in Children

MONDAY, Nov. 10, 2014 (HealthDay News) -- In some children with chronic spontaneous urticaria (CSU), exacerbations may be caused by hypersensitivity to aspirin, according to research published online Oct. 29 in Allergy.

Abstract
Full Text (subscription or payment may be required)

Most Minor Cosmetic Procedures Safe When Done by Experts

FRIDAY, Nov. 7, 2014 (HealthDay News) -- Noninvasive to minimally invasive cosmetic procedures are nearly risk-free when performed by dermatologists at practices focused on cosmetic dermatology, according to a study published online Nov. 5 in JAMA Dermatology.

Full Article
Abstract
Full Text (subscription or payment may be required)

Want to Be a Leader? Cultivate a Healthy Look

FRIDAY, Nov. 7, 2014 (HealthDay News) -- It's more important for potential business or political leaders to look healthy than intelligent, according to a study published online Nov. 5 in Frontiers in Human Neuroscience.

Full Article
Full Text

Climate Change Will Boost Grass Pollen Production

FRIDAY, Nov. 7, 2014 (HealthDay News) -- Climate change will boost levels of grass pollen in the air in the next 100 years, resulting in more allergen exposure, according to a study published online Nov. 5 in PLOS ONE.

Full Article
Full Text

Better Physician Communication at Shift Change Reduces Errors

FRIDAY, Nov. 7, 2014 (HealthDay News) -- Changing how doctors communicate during shift changes in hospitals reduces the risk of adverse events in patients by 30 percent, according to a study published in the Nov. 6 issue of the New England Journal of Medicine.

Full Article
Full Text (subscription or payment may be required)

Docs Spend ~16.6 Percent of Their Time on Administration

FRIDAY, Nov. 7, 2014 (HealthDay News) -- About 16.6 percent of doctors' working hours are spent on administrative work, according to a study published recently in the International Journal of Health Services.

Full Text (subscription or payment may be required)

BADGE Exposure Can Elicit Contact Allergy Reactions

THURSDAY, Nov. 6, 2014 (HealthDay News) -- Exposure to aluminum tubes for pharmaceutical use that are internally lacquered with epoxy resins (ER) based on bisphenol A diglycidyl ether (BADGE) can elicit contact allergy reactions, according to a study published online Oct. 29 in Allergy.

Abstract
Full Text (subscription or payment may be required)

AMA: New Mapping Tool IDs Areas in Need of Physicians

WEDNESDAY, Nov. 5, 2014 (HealthDay News) -- A new interactive mapping tool can help physicians and their staff determine locations to establish or expand their practice, according to a report published by the American Medical Association (AMA).

More Information

Opening Visitation Access Boosts Patient, Family Experience

TUESDAY, Nov. 4, 2014 (HealthDay News) -- Opening visitation access across all facilities can improve patient and family experience, according to research published in the July/August issue of the Journal of Nursing Administration.

Full Text (subscription or payment may be required)

Combo Tx for Advanced Melanoma Found to Up Survival

TUESDAY, Nov. 4, 2014 (HealthDay News) -- Patients with advanced melanoma may live longer when treated with a combination of ipilimumab (Yervoy) and sargramostim, compared to being treated with ipilimumab alone, according to a new study published in the Nov. 5 issue of the Journal of the American Medical Association.

Full Article
Abstract
Full Text (subscription or payment may be required)

Long-Term Shift Work May Drain the Brain

TUESDAY, Nov. 4, 2014 (HealthDay News) -- Working non-standard hours -- "shift work" -- for many years is not only hard on the body, but may also dull the mind, new research suggests. According to the study, published online Nov. 3 in Occupational & Environmental Medicine, those who do shift work for more than 10 years seem to have the equivalent of an extra 6.5 years of age-related decline in memory and thinking skills.

Full Article
Abstract
Full Text (subscription or payment may be required)

AMA: Absence of Health Insurer Competition in Many Areas

MONDAY, Nov. 3, 2014 (HealthDay News) -- In most metropolitan areas, there is a significant absence of health insurer competition, according to a report published by the American Medical Association (AMA).

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths